Abstract
Androgens, which are mediated via the androgen receptor (AR), play important roles in normal follicular development and female fertility. However, just like a double-edged sword, besides the positive effects of androgen on follicular development, abnormal androgen levels, especially as in hyperandrogenism, seriously suppress normal follicular development. A crucial balance exists between the importance of androgens in follicular development and their negative effects when in excess. As the first meiotic division and epigenetic reprogramming are two critical events in oogenesis, abnormal androgen levels or deficiency in androgen/AR signaling in the ovary may affect these vital events. Oocytes have a tendency to develop genomic instability, thus resulting in an increasing incidence of unpredictable adult diseases. Although many studies have explored the effects of androgens and AR on follicular development, the conclusions are controversial and there has been no thorough review of this topic. This review focuses on the roles of androgens in the physiological process of follicular development, summarizes new insights into the roles of androgens in the arrested development of follicles, and discusses the potential risk of adult diseases originating from abnormal follicular androgen levels or androgen receptor signals, which may determine areas for future studies.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Matsumoto T, Sakari M, Okada M, et al, 2013 The androgen receptor in health and disease. Annu Rev Physiol 75: 201–224.
Lyon MF, Glenister PH, 1974 Evidence from Tfm-O that androgen is inessential for reproduction in female mice. Nature 247: 366–367.
Lyon MF, Glenister PH, 1980 Reduced reproductive performance in androgen-resistant Tfm/Tfm female mice. Proc R Soc Lond B Biol Sci 208: 1–12.
Sen A, Hammes SR, 2010 Granulosa cell-specific androgen receptors are critical regulators of ovarian development and function. Mol Endocrinol 24: 1393–1403.
Labrie F 2010 DHEA, important source of sex steroids in men and even more in women. In: Martini L, Chrousos GP, Labrie F, et al, (eds) Neuroendocrinology: Pathological Situations and Diseases, Elsevier Science Bv, Amsterdam; pp, 97–148.
Gleicher N, Barad DH, 2011 Dehydroepiandrosterone (DHEA) supplementation in diminished ovarian reserve (DOR). Reprod Biol Endocrinol 9: 67.
Sen A, Prizant H, Light A, et al, 2014 Androgens regulate ovarian follicular development by increasing follicle stimulating hormone receptor and microRNA-125b expression. Proc Natl Acad Sci U S A 111: 3008–3013.
MacDonald PC, Rombaut RP, Siiteri PK, 1967 Plasma precursors of estrogen. I. Extent of conversion of plasma delta-4-androstenedione to estrone in normal males and nonpregnant normal, castrate and adrenalectomized females. J Clin Endocrinol Metab 27: 1103–1111.
Hsueh A, Dahl KD, Vaughan J, et al, 1987 Heterodimers and homodimers of inhibin subunits have different paracrine action in the modulation of luteinizing hormone-stimulated androgen biosynthesis. Proc Natl Acad Sci U S A 84: 5082–5086.
Young JM, McNeilly AS, 2010 Theca: the forgotten cell of the ovarian follicle. Reproduction 140: 489–504.
Eppig JJ, 2001 Oocyte control of ovarian follicular development and function in mammals. Reproduction 122: 829–838.
McGee EA, Hsueh AJ, 2000 Initial and cyclic recruitment of ovarian follicles. Endocr Rev 21: 200–214.
Schramm RD, Bavister B, 1999 A macaque model for studying mechanisms controlling oocyte development and maturation in human and non-human primates. Hum Reprod 14: 2544–2555.
Gervasio CG, Bernuci MP, Silva-de-Sa MF, et al, 2014 The role of androgen hormones in early follicular development. ISRN Obstet Gynecol 2014: 818010.
Li M, Schatten H, Sun QY, 2009 Androgen receptor’s destiny in mammalian oocytes: a new hypothesis. Mol Hum Reprod 15: 149–154.
Prizant H, Gleicher N, Sen A, 2014 Androgen actions in the ovary: balance is key. J Endocrinol 222: R141–R151.
Walters KA, Allan CM, Handelsman DJ, 2008 Androgen actions and the ovary. Biol Reprod 78: 380–389.
Cordray JP, Siboulet B, Merceron RE, et al, 1994 Treatment of female infertility due to hyperandrogenism. Rev Fr Gynecol Obstet 89: 255–266.
Diamond MP, 1989 Hyperandrogenism in infertility. J Reprod Med 34: 10–16.
Dumesic DA, Schramm RD, Peterson E, et al, 2002 Impaired developmental competence of oocytes in adult prenatally androgenized female rhesus monkeys undergoing gonadotropin stimulation for in vitro fertilization. J Clin Endocrinol Metab 87: 1111–1119.
Jabara S, Coutifaris C, 2003 In vitro fertilization in the PCOS patient: clinical considerations. Semin Reprod Med 21: 317–324.
Dumesic DA, Schramm RD, Bird IM, et al, 2003 Reduced intrafollicular androstenedione and estradiol levels in early-treated prenatally androgenized female rhesus monkeys receiving follicle-stimulating hormone therapy for in vitro fertilization. Biol Reprod 69: 1213–1219.
Teissier MP, Chable H, Paulhac S, et al, 2000 Comparison of follicle steroidogenesis from normal and polycystic ovaries in women undergoing IVF: relationship between steroid concentrations, follicle size, oocyte quality and fecundability. Hum Reprod 15: 2471–2477.
Farookhi R, 1985 Effects of aromatizable and nonaromatizable androgen treatments on luteinizing hormone receptors and ovulation induction in immature rats. Biol Reprod 33: 363–369.
Almahbobi G, Nagodavithane A, Trounson AO, 1995 Effects of epidermal growth factor, transforming growth factor alpha and androstenedione on follicular growth and aromatization in culture. Hum Reprod 10: 2767–2772.
Racowsky C, 1983 Androgenic modulation of cyclic adenosine monophosphate (cAMP)-dependent meiotic arrest. Biol Reprod 28: 774–787.
Norman RJ, Dewailly D, Legro RS, et al, 2007 Polycystic ovary syndrome. Lancet 370: 685–697.
Smith DM, Tenney DY, 1980 Effects of steroids on mouse oocyte maturation in vitro. J Reprod Fertil 60: 331–338.
Eppig JJ, Freter RR, Ward-Bailey PF, et al, 1983 Inhibition of oocyte maturation in the mouse: participation of cAMP, steroid hormones, and a putative maturation-inhibitory factor. Dev Biol 100: 39–49.
Schultz RM, Montgomery RR, Ward-Bailey PF, et al, 1983 Regulation of oocyte maturation in the mouse: possible roles of intercellular communication, cAMP, and testosterone. Dev Biol 95: 294–304.
Anderiesz C, Trounson AO, 1995 The effect of testosterone on the maturation and developmental capacity of murine oocytes in vitro. Hum Reprod 10: 2377–2381.
Hu YC, Wang PH, Yeh S, et al, 2004 Subfertility and defective folliculogenesis in female mice lacking androgen receptor. Proc Natl Acad Sci U S A 101: 11209–11214.
Shiina H, Matsumoto T, Sato T, et al, 2006 Premature ovarian failure in androgen receptor-deficient mice. Proc Natl Acad Sci U S A 103: 224–229.
Walters KA, Allan CM, Jimenez M, et al, 2007 Female mice haploinsufficient for an inactivated androgen receptor (AR) exhibit age-dependent defects that resemble the AR null phenotype of dysfunctional late follicle development, ovulation, and fertility. Endocrinology 148: 3674–3684.
Yeh S, Tsai MY, Xu Q, et al, 2002 Generation and characterization of androgen receptor knockout (ARKO) mice: an in vivo model for the study of androgen functions in selective tissues. Proc Natl Acad Sci U S A 99: 13498–13503.
Gleicher N, Weghofer A, Barad DH, 2011 The role of androgens in follicle maturation and ovulation induction: friend or foe of infertility treatment? Reprod Biol Endocrinol 9: 116.
Gleicher N, Kim A, Weghofer A, et al, 2013 Starting and resulting testosterone levels after androgen supplementation determine at all ages in vitro fertilization (IVF) pregnancy rates in women with diminished ovarian reserve (DOR). J Assist Reprod Genet 30: 49–62.
Lubahn DB, Joseph DR, Sullivan PM, et al, 1988 Cloning of human androgen receptor complementary DNA and localization to the X chromosome. Science 240: 327–330.
Sullivan SD, Moenter SM, 2004 Prenatal androgens alter GABAergic drive to gonadotropin-releasing hormone neurons: implications for a common fertility disorder. Proc Natl Acad Sci U S A 101: 7129–7134.
Dart DA, Waxman J, Aboagye EO, et al, 2013 Visualising androgen receptor activity in male and female mice. PLoS One 8: e71694.
Hillier SG, Tetsuka M, Fraser HM, 1997 Location and developmental regulation of androgen receptor in primate ovary. Hum Reprod 12: 107–111.
Juengel JL, Heath DA, Quirke LD, et al, 2006 Oestrogen receptor alpha and beta, androgen receptor and progesterone receptor mRNA and protein localisation within the developing ovary and in small growing follicles of sheep. Reproduction 131: 81–92.
Lenie S, Smitz J, 2009 Functional AR signaling is evident in an in vitro mouse follicle culture bioassay that encompasses most stages of folliculogenesis. Biol Reprod 80: 685–695.
Murray AA, Gosden RG, Allison V, et al, 1998 Effect of androgens on the development of mouse follicles growing in vitro. J Reprod Fertil 113: 27–33.
Wang H, Andoh K, Hagiwara H, et al, 2001 Effect of adrenal and ovarian androgens on type 4 follicles unresponsive to FSH in immature mice. Endocrinology 142: 4930–4936.
Vendola KA, Zhou J, Adesanya OO, et al, 1998 Androgens stimulate early stages of follicular growth in the primate ovary. J Clin Invest 101: 2622–2629.
Cardenas H, Herrick JR, Pope WF, 2002 Increased ovulation rate in gilts treated with dihydrotestosterone. Reproduction 123: 527–533.
Vendola K, Zhou J, Wang J, et al, 1999 Androgens promote oocyte insulin-like growth factor I expression and initiation of follicle development in the primate ovary. Biol Reprod 61: 353–357.
Vendola K, Zhou J, Wang J, et al, 1999 Androgens promote insulin-like growth factor-I and insulin-like growth factor-I receptor gene expression in the primate ovary. Hum Reprod 14: 2328–2332.
Hickey TE, Marrocco D, Gilchrist RB, et al, 2004 Interactions between androgen and growth factors in granulosa cell subtypes of porcine antral follicles. Biol Reprod 71: 45–52.
Hickey TE, Marrocco DL, Amato F, et al, 2005 Androgens augment the mitogenic effects of oocyte-secreted factors and growth differentiation factor 9 on porcine granulosa cells. Biol Reprod 73: 825–832.
Weil SJ, Vendola K, Zhou J, et al, 1998 Androgen receptor gene expression in the primate ovary: cellular localization, regulation, and functional correlations. J Clin Endocrinol Metab 83: 2479–2485.
Walters KA, Middleton LJ, Joseph SR, et al, 2012 Targeted loss of androgen receptor signaling in murine granulosa cells of preantral and antral follicles causes female subfertility. Biol Reprod 87: 151.
Jonard S, Dewailly D, 2004 The follicular excess in polycystic ovaries, due to intra-ovarian hyperandrogenism, may be the main culprit for the follicular arrest. Hum Reprod Update 10: 107–117.
Abbott DH, Dumesic DA, Eisner JR, et al, 1998 Insights into the development of polycystic ovary syndrome (PCOS) from studies of prenatally androgenized female rhesus monkeys. Trends Endocrinol Metab 9: 62–67.
Utilenbroek JT, Arendsen de Wolf-Exalto E, Blankenstein MA, 1976 Serum gonadotrophins and follicular development in immature rats after early androgen administration. J Endocrinol 68: 461–468.
Qu F, Wang FF, Lu XE, et al, 2010 Altered aquaporin expression in women with polycystic ovary syndrome: hyperandrogenism in follicular fluid inhibits aquaporin-9 in granulosa cells through the phosphatidylinositol 3-kinase pathway. Hum Reprod 25: 1441–1450.
Qu F, Wang FF, Yin R, et al, 2012 A molecular mechanism underlying ovarian dysfunction of polycystic ovary syndrome: hyperandrogenism induces epigenetic alterations in the granulosa cells. J Mol Med (Berl) 90: 911–923.
Taylor AE, McCourt B, Martin KA, et al, 1997 Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome. J Clin Endocrinol Metab 82: 2248–2256.
Eagleson CA, Gingrich MB, Pastor CL, et al, 2000 Polycystic ovarian syndrome: Evidence that flutamide restores sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone. J Clin Endocrinol Metab 85: 4047–4052.
Chhabra S, McCartney CR, Yoo RY, et al, 2005 Progesterone inhibition of the hypothalamic gonadotropin-releasing hormone pulse generator: Evidence for varied effects in hyperandrogenemic adolescent girls. J Clin Endocrinol Metab 90: 2810–2815.
Diamanti-Kandarakis E, 2008 Polycystic ovarian syndrome: pathophysiology, molecular aspects and clinical implications. Expert Rev Mol Med 10: e3.
Barnes RB, Namnoum AB, Rosenfield RL, et al, 2002 The role of LH and FSH in ovarian androgen secretion and ovarian follicular development: clinical studies in a patient with isolated FSH deficiency and multicystic ovaries. Hum Reprod 17: 88–91.
DeUgarte CM, Bartolucci AA, Azziz R, 2005 Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment. Fertil Steril 83: 1454–1460.
Abbott DH, Bacha F, 2013 Ontogeny of polycystic ovary syndrome and insulin resistance in utero and early childhood. Fertil Steril 100: 2–11.
Poretsky L, Cataldo NA, Rosenwaks Z, et al, 1999 The insulin-related ovarian regulatory system in health and disease. Endocr Rev 20: 535–582.
Baillargeon JP, Carpentier A, 2007 Role of insulin in the hyperandrogenemia of lean women with polycystic ovary syndrome and normal insulin sensitivity. Fertil Steril 88: 886–893.
Diamanti-Kandarakis E, Papavassiliou AG, 2006 Molecular mechanisms of insulin resistance in polycystic ovary syndrome. Trends Mol Med 12: 324–332.
Nelson VL, Legro RS, Strauss JF, et al, 1999 Augmented androgen production is a stable steroidogenic phenotype of propagated theca cells from polycystic ovaries. Mol Endocrinol 13: 946–957.
Wood JR, Ho CKM, Nelson-Degrave VL, et al, 2004 The molecular signature of polycystic ovary syndrome (PCOS) theca cells defined by gene expression profiling. J Reprod Immuno 63: 51–60.
Wickenheisser JK, Nelson-DeGrave VL, McAllister JM, 2005 Dysregulation of cytochrome P450 17 alpha-hydroxylase messenger ribonucleic acid stability in theca cells isolated from women with polycystic ovary syndrome. J Clin Endocrinol Metab 90: 1720–1727.
Pandey AV, Mellon SH, Miller WL, 2003 Protein phosphatase 2A and phosphoprotein SET regulate androgen production by P450c17. J Biol Chem 278: 2837–2844.
Durlinger A, Visser JA, Themmen A, 2002 Regulation of ovarian function: the role of anti-Mullerian hormone. Reproduction 124: 601–609.
Rajpert-De Meyts E, Jorgensen N, Graem N, et al, 1999 Expression of anti-Mullerian hormone during normal and pathological gonadal development: Association with differentiation of Sertoli and granulosa cells. J Clin Endocrinol Metab 84: 3836–3844.
Eldar-Geva T, Margalioth EJ, Gal M, et al, 2005 Serum anti-Mullerian hormone levels during controlled ovarian hyperstimulation in women with polycystic ovaries with and without hyperandrogenism. Hum Reprod 20: 1814–1819.
Eldar-Geva T, Margalioth EJ, Gal M, et al, 2005 Serum anti-Mullerian hormone levels during controlled ovarian hyperstimulation in women with polycystic ovaries with and without hyperandrogenism. Hum Reprod 20: 1814–1819.
Sahmay S, Atakul N, Oncul M, et al, 2013 Serum anti-mullerian hormone levels in the main phenotypes of polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol 170: 157–161.
Escobar-Morreale HF, Calvo RM, Sancho J, et al, 2001 TNF-α and hyperandrogenism: a clinical, biochemical, and molecular genetic study. J Clin Endocrinol Metab 86: 3761–3767.
Pan JX, Wang FF, Liu Y, Meng Q, Sheng JZ, Huang HF, 2013 Bisphenol a (BPA) induces abnormal androgen accumulation via androgen-androgen receptor (AR) mdiated cyp19a1 transcription inhibition in granulosa cells (GCs). Fertil Steril 100: S13.
Wang FF, Pan JX, Liu Y, et al, 2013 Alternatively spliced variants of androgen receptor in granulosa cells: an epigenetic cause of ovarian hyperandrogenism of polycystic ovary syndrome. Fertil Steril 100: S2.
Rochester JR, 2013 Bisphenol A and human health: a review of the literature. Reprod Toxicol 42: 132–155.
Zhou W, Liu HY, Liao LM, et al, 2008 Effect of bisphenol A on steroid hormone production in rat ovarian theca-interstitial and granulosa cells. Mol Cell Endocrinol 283: 12–18.
Takeuchi T, Tsutsumi O, Ikezuki Y, et al, 2004 Positive relationship between androgen and the endocrine disruptor, bisphenol A, in normal women and women with ovarian dysfunction. Endocr J 51: 165–169.
Richards JS, Russell DL, Robker RL, et al, 1998 Molecular mechanisms of ovulation and luteinization. Mol Cell Endocrinol 145: 47–54.
McGee EA, Hsueh AJ, 2000 Initial and Cyclic Recruitment of Ovarian Follicles 1. Endocr Rev 21: 200–214.
Hsueh AJ, Billig H, Tsafriri A, 1994 Ovarian follicle atresia: a hormonally controlled apoptotic process. Endocr Rev 15: 707–724.
Kaipia A, Hsueh AJ, 1997 Regulation of ovarian follicle atresia. Annu Rev Physiol 59: 349–363.
Bagnell CA, Mills TM, Costoff A, et al, 1982 A model for the study of androgen effects on follicular atresia and ovulation. Biol Reprod 27: 903–914.
Zeleznik AJ, Hillier SG, Ross GT, 1979 Follicle stimulating hormone-induced follicular development: an examination of the role of androgens. Biol Reprod 21: 673–681.
Bagnell C, Mills T, Costoff A, 1982 A Model for the Study of Androgen Effects. Biol Reprod 27: 903–914.
Billig H, Furuta I, Hsueh AJ, 1993 Estrogens inhibit and androgens enhance ovarian granulosa cell apoptosis. Endocrinology 133: 2204–2212.
Tesarik J, Mendoza C, 1997 Direct non-genomic effects of follicular steroids on maturing human oocytes: oestrogen versus androgen antagonism. Hum Reprod Update 3: 95–100.
Brailly S, Gougeon A, Milgrom E, et al, 1981 Androgens and Progestins in the Human Ovarian Follicle: Differences in the Evolution of Preovulatory, Healthy Nonovulatory, and Atretic Follicles. J Clin Endocrinol Metab 53: 128–134.
Hammes SR, 2004 Steroids and oocyte maturation-a new look at an old story. Mol Endocrinol 18: 769–775.
Smith DM, Tenney D, 1980 Effects of steroids on mouse oocyte maturation in vitro. J Reprod Fertil 60: 331–338.
Tesarik J, Mendoza C, 1995 Nongenomic effects of 17 beta-estradiol on maturing human oocytes: relationship to oocyte developmental potential. J Clin Endocrinol Metab 80: 1438–1443.
Pradeep PK, Li X, Peegel H, et al, 2002 Dihydrotestosterone inhibits granulosa cell proliferation by decreasing the cyclin D2 mRNA expression and cell cycle arrest at G1 phase. Endocrinology 143: 2930–2935.
Andersen CY, 1993 Characteristics of human follicular fluid associated with successful conception after in vitro fertilization. J Clin Endocrinol Metab 77: 1227–1234.
Brzyski RG, Grow DR, Sims JA, et al, 1995 Increase in androgen:estrogen ratio specifically during low-dose follicle-stimulating hormone therapy for polycystic ovary syndrome. Fertil Steril 64: 693–697.
De Leo V, Lanzetta D, D’Antona D, et al, 1998 Hormonal effects of flutamide in young women with polycystic ovary syndrome. J Clin Endocrinol Metab 83: 99–102.
Magoffin D, Jakimiuk A, 1997 Inhibin A, inhibin B and activin A in the follicular fluid of regularly cycling women. Hum Reprod 12: 1714–1719.
Welt CK, Taylor AE, Fox J, et al, 2005 Follicular arrest in polycystic ovary syndrome is associated with deficient inhibin A and B biosynthesis. J Clin Endocrinol Metab 90: 5582–5587.
Payne RW, Hellbaum AA, Owens JN Jr, 1956 The effect of androgens on the ovaries and uterus of the estrogen treated hypophysectomized immature rat. Endocrinology 59: 306–316.
Qu F, Chen LT, Pan HJ, Huang HF 2014 Gamete/Embryo-Fetal Origins of Mental Disorders. In: Huang HF, Sheng JZ (eds) Gamete and Embryo-fetal Origins of Adult Diseases, Springer Science+Business Media, Dordrecht; pp, 157–172.
Reik W, Dean W, Walter J, 2001 Epigenetic reprogramming in mammalian development. Science 293: 1089–1093.
Dong MY, Wang FF, Pan JX, Huang HF 2014 Adverse Intrauterine Environment and Gamete/Embryo-Fetal Origins of Diseases. In: Huang HF, Sheng JZ (eds) Gamete and Embryo-fetal Origins of Adult Diseases, Springer Science+Business Media, Dordrecht; pp, 61–78.
Nicholas CR, Chavez SL, Baker VL, et al, 2009 Instructing an embryonic stem cell-derived oocyte fate: lessons from endogenous oogenesis. Endocr Rev 30: 264–283.
Gallou-Kabani C, Junien C, 2005 Nutritional epigenomics of metabolic syndrome new perspective against the epidemic. Diabetes 54: 1899–1906.
Bruns CM, Baum ST, Colman RJ, et al, 2004 Insulin resistance and impaired insulin secretion in prenatally androgenized male rhesus monkeys. J Clin Endocrinol Metab 89: 6218–6223.
Nilsson C, Niklasson M, Eriksson E, et al, 1998 Imprinting of female offspring with testosterone results in insulin resistance and changes in body fat distribution at adult age in rats. J Clin Invest 101: 74.
Carlsen S, Jacobsen G, Romundstad P, 2006 Maternal testosterone levels during pregnancy are associated with offspring size at birth. Eur J Endocrinol 155: 365–370.
Sir-Petermann T, Hitchsfeld C, Maliqueo M, et al, 2005 Birth weight in offspring of mothers with polycystic ovarian syndrome. Hum Reprod 20: 2122–2126.
Sir-Petermann T, Codner E, Maliqueo M, et al, 2006 Increased anti-Mullerian hormone serum concentrations in prepubertal daughters of women with polycystic ovary syndrome. J Clin Endocrinol Metab 91: 3105–3109.
Crisosto N, Codner E, Maliqueo M, et al, 2007 Anti-Mullerian hormone levels in peripubertal daughters of women with polycystic ovary syndrome. J Clin Endocrinol Metab 92: 2739–2743.
Perera F, Herbstman J, 2011 Prenatal environmental exposures, epigenetics, and disease. Reprod Toxicol 31: 363–373.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pan, JX., Zhang, JY., Ke, ZH. et al. Androgens as double-edged swords: Induction and suppression of follicular development. Hormones 14, 190–200 (2015). https://doi.org/10.14310/horm.2002.1580
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.14310/horm.2002.1580